{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:33:40Z","timestamp":1790883220067,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Rudolf Virchow Centre for Integrative and Translational Bioimaging"},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["HL082808"],"award-info":[{"award-number":["HL082808"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 HL120877"],"award-info":[{"award-number":["UM1 HL120877"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["INST 93\/1022-1"],"award-info":[{"award-number":["INST 93\/1022-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["453989101"],"award-info":[{"award-number":["453989101"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["374031971"],"award-info":[{"award-number":["374031971"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Ni556\/14-1"],"award-info":[{"award-number":["Ni556\/14-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union (Thrombo-Inflame, EFRE\u2013Europ\u00e4ischer Fonds f\u00fcr regionale Entwicklung, Bavaria) Rudolf Virchow Centre for Integrative and Translational Bioimaging"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cardiovasc Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The activation of platelets and coagulation at vascular injury sites is crucial for hemostasis but can promote thrombosis and inflammation in vascular pathologies. Here, we delineate an unexpected spatio-temporal control mechanism of thrombin activity that is platelet orchestrated and locally limits excessive fibrin formation after initial hemostatic platelet deposition. During platelet activation, the abundant platelet glycoprotein (GP)V is cleaved by thrombin. We demonstrate, with genetic and pharmacological approaches, that thrombin-mediated shedding of GPV does not primarily regulate platelet activation in thrombus formation but rather has a distinct function after platelet deposition and specifically limits thrombin-dependent generation of fibrin, a crucial mediator of vascular thrombo-inflammation. Genetic or pharmacologic defects in hemostatic platelet function are unexpectedly attenuated by specific blockade of GPV shedding, indicating that the spatio-temporal control of thrombin-dependent fibrin generation also represents a potential therapeutic target to improve hemostasis.<\/jats:p>","DOI":"10.1038\/s44161-023-00254-6","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T13:03:19Z","timestamp":1679576599000},"page":"368-382","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Platelet glycoprotein V spatio-temporally controls fibrin formation"],"prefix":"10.1038","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7102-8241","authenticated-orcid":false,"given":"Sarah","family":"Beck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0967-0049","authenticated-orcid":false,"given":"Patricia","family":"\u00d6ftering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5806-5080","authenticated-orcid":false,"given":"Renhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1852-6513","authenticated-orcid":false,"given":"Katherina","family":"Hemmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdolna","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Zarpellon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.","family":"Schuhmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Stoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0807-1295","authenticated-orcid":false,"given":"Zaverio M.","family":"Ruggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2372-6800","authenticated-orcid":false,"given":"Katrin G.","family":"Heinze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan W. M.","family":"Heemskerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6064-2166","authenticated-orcid":false,"given":"Wolfram","family":"Ruf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1059-9865","authenticated-orcid":false,"given":"David","family":"Stegner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1454-7413","authenticated-orcid":false,"given":"Bernhard","family":"Nieswandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,23]]},"reference":[{"key":"254_CR1","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/rth2.12107","volume":"2","author":"F Swieringa","year":"2018","unstructured":"Swieringa, F., Spronk, H. M. H., Heemskerk, J. W. M. & van der Meijden, P. E. J. Integrating platelet and coagulation activation in fibrin clot formation. Res. Pract. Thromb. Haemost. 2, 450\u2013460 (2018).","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"254_CR2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/0092-8674(88)90567-3","volume":"53","author":"B Furie","year":"1988","unstructured":"Furie, B. & Furie, B. C. The molecular basis of blood coagulation. Cell 53, 505\u2013518 (1988).","journal-title":"Cell"},{"key":"254_CR3","first-page":"1","volume":"6","author":"M Tomaiuolo","year":"2017","unstructured":"Tomaiuolo, M., Brass, L. F. & Stalker, T. J. Regulation of platelet activation and coagulation and its role in vascular injury and arterial thrombosis. Interv. Cardiol. Clin. 6, 1\u201312 (2017).","journal-title":"Interv. Cardiol. Clin."},{"key":"254_CR4","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/29325","volume":"394","author":"ML Kahn","year":"1998","unstructured":"Kahn, M. L. et al. A dual thrombin receptor system for platelet activation. Nature 394, 690\u2013694 (1998).","journal-title":"Nature"},{"key":"254_CR5","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1182\/blood-2012-09-457739","volume":"121","author":"TJ Stalker","year":"2013","unstructured":"Stalker, T. J. et al. Hierarchical organization in the hemostatic response and its relationship to the platelet-signaling network. Blood 121, 1875\u20131885 (2013).","journal-title":"Blood"},{"key":"254_CR6","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1152\/physrev.00016.2011","volume":"93","author":"HH Versteeg","year":"2013","unstructured":"Versteeg, H. H., Heemskerk, J. W., Levi, M. & Reitsma, P. H. New fundamentals in hemostasis. Physiol. Rev. 93, 327\u2013358 (2013).","journal-title":"Physiol. Rev."},{"key":"254_CR7","doi-asserted-by":"publisher","first-page":"100733","DOI":"10.1016\/j.blre.2020.100733","volume":"46","author":"Y Sang","year":"2021","unstructured":"Sang, Y., Roest, M., de Laat, B., de Groot, P. G. & Huskens, D. Interplay between platelets and coagulation. Blood Rev. 46, 100733 (2021).","journal-title":"Blood Rev."},{"key":"254_CR8","doi-asserted-by":"publisher","first-page":"eabl5450","DOI":"10.1126\/science.abl5450","volume":"374","author":"LM Silva","year":"2021","unstructured":"Silva, L. M. et al. Fibrin is a critical regulator of neutrophil effector function at the oral mucosal barrier. Science 374, eabl5450 (2021).","journal-title":"Science"},{"key":"254_CR9","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/s41590-018-0232-x","volume":"19","author":"JK Ryu","year":"2018","unstructured":"Ryu, J. K. et al. Fibrin-targeting immunotherapy protects against neuroinflammation and neurodegeneration. Nat. Immunol. 19, 1212\u20131223 (2018).","journal-title":"Nat. Immunol."},{"key":"254_CR10","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1182\/blood-2006-09-003004","volume":"109","author":"LO Mosnier","year":"2006","unstructured":"Mosnier, L. O., Zlokovic, B. V. & Griffin, J. H. The cytoprotective protein C pathway. Blood 109, 3161\u20133172 (2006).","journal-title":"Blood"},{"key":"254_CR11","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1160\/TH10-09-0578","volume":"104","author":"ZM Ruggeri","year":"2010","unstructured":"Ruggeri, Z. M. et al. Unravelling the mechanism and significance of thrombin binding to platelet glycoprotein Ib. Thromb. Haemost. 104, 894\u2013902 (2010).","journal-title":"Thromb. Haemost."},{"key":"254_CR12","doi-asserted-by":"publisher","first-page":"4112","DOI":"10.1182\/blood.V94.12.4112","volume":"94","author":"ML Kahn","year":"1999","unstructured":"Kahn, M. L. et al. Glycoprotein V-deficient platelets have undiminished thrombin responsiveness and do not exhibit a Bernard\u2013Soulier phenotype. Blood 94, 4112\u20134121 (1999).","journal-title":"Blood"},{"key":"254_CR13","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/jth.12144","volume":"11","author":"R Li","year":"2013","unstructured":"Li, R. & Emsley, J. The organizing principle of the platelet glycoprotein Ib\u2013IX\u2013V complex. J. Thromb. Haemost. 11, 605\u2013614 (2013).","journal-title":"J. Thromb. Haemost."},{"key":"254_CR14","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1111\/j.1538-7836.2012.04841.x","volume":"10","author":"X Mo","year":"2012","unstructured":"Mo, X., Liu, L., Lopez, J. A. & Li, R. Transmembrane domains are critical to the interaction between platelet glycoprotein V and glycoprotein Ib\u2013IX complex. J. Thromb. Haemost. 10, 1875\u20131886 (2012).","journal-title":"J. Thromb. Haemost."},{"key":"254_CR15","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1182\/blood.V98.4.1038","volume":"98","author":"S Moog","year":"2001","unstructured":"Moog, S. et al. Platelet glycoprotein V binds to collagen and participates in platelet adhesion and aggregation. Blood 98, 1038\u20131046 (2001).","journal-title":"Blood"},{"key":"254_CR16","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1182\/blood-2002-12-3882","volume":"102","author":"B Nieswandt","year":"2003","unstructured":"Nieswandt, B. & Watson, S. P. Platelet\u2013collagen interaction: is GPVI the central receptor? Blood 102, 449\u2013461 (2003).","journal-title":"Blood"},{"key":"254_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1160\/TH07-05-0327","volume":"98","author":"KJ Clemetson","year":"2007","unstructured":"Clemetson, K. J. A short history of platelet glycoprotein Ib complex. Thromb. Haemost. 98, 63\u201368 (2007).","journal-title":"Thromb. Haemost."},{"key":"254_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0049-3848(98)00111-X","volume":"92","author":"S Katsutani","year":"1998","unstructured":"Katsutani, S. et al. Cloning and characterization of the gene encoding the murine glycoprotein V: the conserved thrombin-cleavable protein on platelet surface. Thromb. Res. 92, 43\u201351 (1998).","journal-title":"Thromb. Res."},{"key":"254_CR19","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1182\/blood.V89.9.3253","volume":"89","author":"C Ravanat","year":"1997","unstructured":"Ravanat, C. et al. Gene cloning of rat and mouse platelet glycoprotein V: identification of megakaryocyte-specific promoters and demonstration of functional thrombin cleavage. Blood 89, 3253\u20133262 (1997).","journal-title":"Blood"},{"key":"254_CR20","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1182\/blood.V98.2.368","volume":"98","author":"H Ni","year":"2001","unstructured":"Ni, H. Increased thrombogenesis and embolus formation in mice lacking glycoprotein V. Blood 98, 368\u2013373 (2001).","journal-title":"Blood"},{"key":"254_CR21","doi-asserted-by":"publisher","first-page":"14462","DOI":"10.1074\/jbc.M500041200","volume":"280","author":"T Rabie","year":"2005","unstructured":"Rabie, T., Strehl, A., Ludwig, A. & Nieswandt, B. Evidence for a role of ADAM17 (TACE) in the regulation of platelet glycoprotein V. J. Biol. Chem. 280, 14462\u201314468 (2005).","journal-title":"J. Biol. Chem."},{"key":"254_CR22","doi-asserted-by":"publisher","first-page":"13336","DOI":"10.1073\/pnas.96.23.13336","volume":"96","author":"V Ramakrishnan","year":"1999","unstructured":"Ramakrishnan, V. et al. Increased thrombin responsiveness in platelets from mice lacking glycoprotein V. Proc. Natl Acad. Sci. USA 96, 13336\u201313341 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"254_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1538-7836.2007.02825.x","volume":"6","author":"C Nonne","year":"2008","unstructured":"Nonne, C., Hechler, B., Cazenave, J. P., Gachet, C. & Lanza, F. Reassessment of in vivo thrombus formation in glycoprotein V deficient mice backcrossed on a C57Bl\/6 strain. J. Thromb. Haemost. 6, 210\u2013212 (2008).","journal-title":"J. Thromb. Haemost."},{"key":"254_CR24","doi-asserted-by":"publisher","first-page":"11243","DOI":"10.1016\/S0021-9258(17)44409-7","volume":"258","author":"EB McGowan","year":"1983","unstructured":"McGowan, E. B., Ding, A. & Detwiler, T. C. Correlation of thrombin-induced glycoprotein V hydrolysis and platelet activation. J. Biol. Chem. 258, 11243\u201311248 (1983).","journal-title":"J. Biol. Chem."},{"key":"254_CR25","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1182\/blood-2015-04-638387","volume":"127","author":"B Estevez","year":"2016","unstructured":"Estevez, B. et al. Signaling-mediated cooperativity between glycoprotein Ib\u2013IX and protease-activated receptors in thrombin-induced platelet activation. Blood 127, 626\u2013636 (2016).","journal-title":"Blood"},{"key":"254_CR26","doi-asserted-by":"publisher","first-page":"218\u2013221","DOI":"10.1126\/science.1084183","volume":"301","author":"R Celikel","year":"2003","unstructured":"Celikel, R. et al. Modulation of \u03b1-thrombin function by distinct interactions with platelet glycoprotein Ib\u03b1. Science 301, 218\u2013221 (2003).","journal-title":"Science"},{"key":"254_CR27","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1126\/science.1083917","volume":"301","author":"JJ Dumas","year":"2003","unstructured":"Dumas, J. J., Kumar, R., Seehra, J., Somers, W. S. & Mosyak, L. Crystal structure of the GpIb\u03b1\u2013thrombin complex essential for platelet aggregation. Science 301, 222\u2013226 (2003).","journal-title":"Science"},{"key":"254_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1084\/jem.20020945","volume":"197","author":"S Massberg","year":"2003","unstructured":"Massberg, S. et al. A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J. Exp. Med. 197, 41\u201349 (2003).","journal-title":"J. Exp. Med."},{"key":"254_CR29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s44161-021-00017-1","volume":"1","author":"D Stegner","year":"2022","unstructured":"Stegner, D. et al. Foudroyant cerebral venous (sinus) thrombosis triggered through CLEC-2 and GPIIb\/IIIa dependent platelet activation. Nat. Cardiovasc. Res. 1, 132\u2013141 (2022).","journal-title":"Nat. Cardiovasc. Res."},{"key":"254_CR30","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1161\/ATVBAHA.112.300672","volume":"33","author":"M Bender","year":"2013","unstructured":"Bender, M. et al. Combined in vivo depletion of glycoprotein VI and C-type lectin-like receptor 2 severely compromises hemostasis and abrogates arterial thrombosis in mice. Arterioscler. Thromb. Vasc. Biol. 33, 926\u2013934 (2013).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"254_CR31","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1084\/jem.193.4.459","volume":"193","author":"B Nieswandt","year":"2001","unstructured":"Nieswandt, B. et al. Long-term antithrombotic protection by in vivo depletion of platelet glycoprotein VI in mice. J. Exp. Med. 193, 459\u2013469 (2001).","journal-title":"J. Exp. Med."},{"key":"254_CR32","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1182\/blood-2005-10-4244","volume":"107","author":"P Mangin","year":"2006","unstructured":"Mangin, P. et al. Thrombin overcomes the thrombosis defect associated with platelet GPVI\/FcR\u03b3 deficiency. Blood 107, 4346\u20134353 (2006).","journal-title":"Blood"},{"key":"254_CR33","doi-asserted-by":"publisher","first-page":"898","DOI":"10.3324\/haematol.2017.182972","volume":"103","author":"PH Mangin","year":"2018","unstructured":"Mangin, P. H. et al. Immobilized fibrinogen activates human platelets through glycoprotein VI. Haematologica 103, 898\u2013907 (2018).","journal-title":"Haematologica"},{"key":"254_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5257","volume":"5","author":"SM de Witt","year":"2014","unstructured":"de Witt, S. M. et al. Identification of platelet function defects by multi-parameter assessment of thrombus formation. Nat. Commun. 5, 4257 (2014).","journal-title":"Nat. Commun."},{"key":"254_CR35","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3389\/fcvm.2019.00099","volume":"6","author":"M Nagy","year":"2019","unstructured":"Nagy, M. et al. Comparative analysis of microfluidics thrombus formation in multiple genetically modified mice: link to thrombosis and hemostasis. Front. Cardiovasc. Med. 6, 99 (2019).","journal-title":"Front. Cardiovasc. Med."},{"key":"254_CR36","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1074\/jbc.M707710200","volume":"283","author":"JC Fredenburgh","year":"2008","unstructured":"Fredenburgh, J. C., Stafford, A. R., Leslie, B. A. & Weitz, J. I. Bivalent binding to \u03b3A\/\u03b3\u2032-fibrin engages both exosites of thrombin and protects it from inhibition by the antithrombin\u2013heparin complex. J. Biol. Chem. 283, 2470\u20132477 (2008).","journal-title":"J. Biol. Chem."},{"key":"254_CR37","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41582-019-0221-1","volume":"15","author":"G Stoll","year":"2019","unstructured":"Stoll, G. & Nieswandt, B. Thrombo-inflammation in acute ischaemic stroke\u2014implications for treatment. Nat. Rev. Neurol. 15, 473\u2013481 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"254_CR38","doi-asserted-by":"publisher","first-page":"25620","DOI":"10.1074\/jbc.M109.000042","volume":"284","author":"NS Petrera","year":"2009","unstructured":"Petrera, N. S. et al. Long range communication between exosites 1 and 2 modulates thrombin function. J. Biol. Chem. 284, 25620\u201325629 (2009).","journal-title":"J. Biol. Chem."},{"key":"254_CR39","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/355564a0","volume":"355","author":"LC Bock","year":"1992","unstructured":"Bock, L. C., Griffin, L. C., Latham, J. A., Vermaas, E. H. & Toole, J. J. Selection of single-stranded DNA molecules that bind and inhibit human thrombin. Nature 355, 564\u2013566 (1992).","journal-title":"Nature"},{"key":"254_CR40","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1006\/jmbi.1997.1275","volume":"272","author":"DM Tasset","year":"1997","unstructured":"Tasset, D. M., Kubik, M. F. & Steiner, W. Oligonucleotide inhibitors of human thrombin that bind distinct epitopes. J. Mol. Biol. 272, 688\u2013698 (1997).","journal-title":"J. Mol. Biol."},{"key":"254_CR41","doi-asserted-by":"publisher","first-page":"2946","DOI":"10.1161\/01.CIR.0000146341.63677.3C","volume":"110","author":"S Gr\u00fcner","year":"2004","unstructured":"Gr\u00fcner, S. et al. Anti-glycoprotein VI treatment severely compromises hemostasis in mice with reduced \u03b12\u03b21 levels or concomitant aspirin therapy. Circulation 110, 2946\u20132951 (2004).","journal-title":"Circulation"},{"key":"254_CR42","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1182\/blood-2011-08-372193","volume":"119","author":"I Pleines","year":"2012","unstructured":"Pleines, I. et al. Megakaryocyte-specific RhoA deficiency causes macrothrombocytopenia and defective platelet activation in hemostasis and thrombosis. Blood 119, 1054\u20131063 (2012).","journal-title":"Blood"},{"key":"254_CR43","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1172\/JCI69210","volume":"123","author":"C Deppermann","year":"2013","unstructured":"Deppermann, C. et al. Gray platelet syndrome and defective thrombo-inflammation in Nbeal2-deficient mice. J. Clin. Invest. 123, 3331\u20133342 (2013).","journal-title":"J. Clin. Invest."},{"key":"254_CR44","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1182\/asheducation-2018.1.576","volume":"2018","author":"T Bakchoul","year":"2018","unstructured":"Bakchoul, T. & Marini, I. Drug-associated thrombocytopenia. Hematology Am. Soc. Hematol. Educ. Program 2018, 576\u2013583 (2018).","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"254_CR45","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1056\/NEJMra066469","volume":"357","author":"RH Aster","year":"2007","unstructured":"Aster, R. H. & Bougie, D. W. Drug-induced immune thrombocytopenia. N. Engl. J. Med. 357, 580\u2013587 (2007).","journal-title":"N. Engl. J. Med."},{"key":"254_CR46","doi-asserted-by":"publisher","first-page":"4938","DOI":"10.1182\/blood-2012-10-461459","volume":"121","author":"M Morowski","year":"2013","unstructured":"Morowski, M. et al. Only severe thrombocytopenia results in bleeding and defective thrombus formation in mice. Blood 121, 4938\u20134947 (2013).","journal-title":"Blood"},{"key":"254_CR47","doi-asserted-by":"publisher","first-page":"eabb8975","DOI":"10.1126\/scitranslmed.abb8975","volume":"14","author":"UDS Sekhon","year":"2022","unstructured":"Sekhon, U. D. S. et al. Platelet-mimicking procoagulant nanoparticles augment hemostasis in animal models of bleeding. Sci. Transl. Med. 14, eabb8975 (2022).","journal-title":"Sci. Transl. Med."},{"key":"254_CR48","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1111\/jth.15697","volume":"20","author":"AE Mast","year":"2022","unstructured":"Mast, A. E. & Ruf, W. Regulation of coagulation by tissue factor pathway inhibitor: implications for hemophilia therapy. J. Thromb. Haemost. 20, 1290\u20131300 (2022).","journal-title":"J. Thromb. Haemost."},{"key":"254_CR49","doi-asserted-by":"publisher","first-page":"10789","DOI":"10.1074\/jbc.M112307200","volume":"277","author":"O Holtkotter","year":"2002","unstructured":"Holtkotter, O. et al. Integrin \u03b12-deficient mice develop normally, are fertile, but display partially defective platelet interaction with collagen. J. Biol. Chem. 277, 10789\u201310794 (2002).","journal-title":"J. Biol. Chem."},{"key":"254_CR50","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1091\/mbc.e09-10-0859","volume":"22","author":"B Jackson","year":"2011","unstructured":"Jackson, B. et al. RhoA is dispensable for skin development, but crucial for contraction and directed migration of keratinocytes. Mol. Biol. Cell 22, 593\u2013605 (2011).","journal-title":"Mol. Biol. Cell"},{"key":"254_CR51","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S0008-6363(98)00306-X","volume":"41","author":"CG Knight","year":"1999","unstructured":"Knight, C. G. et al. Collagen\u2013platelet interaction: Gly-Pro-Hyp is uniquely specific for platelet Gp VI and mediates platelet activation by collagen. Cardiovasc. Res. 41, 450\u2013457 (1999).","journal-title":"Cardiovasc. Res."},{"key":"254_CR52","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.1182\/blood-2002-10-3242","volume":"101","author":"V Schulte","year":"2003","unstructured":"Schulte, V. et al. Targeting of the collagen-binding site on glycoprotein VI is not essential for in vivo depletion of the receptor. Blood 101, 3948\u20133952 (2003).","journal-title":"Blood"},{"key":"254_CR53","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/cyto.10114","volume":"48","author":"W Bergmeier","year":"2002","unstructured":"Bergmeier, W. et al. Flow cytometric detection of activated mouse integrin \u03b1IIb\u03b23 with a novel monoclonal antibody. Cytometry 48, 80\u201386 (2002).","journal-title":"Cytometry"},{"key":"254_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00201-7","volume":"8","author":"D Stegner","year":"2017","unstructured":"Stegner, D. et al. Thrombopoiesis is spatially regulated by the bone marrow vasculature. Nat. Commun. 8, 127 (2017).","journal-title":"Nat. Commun."},{"key":"254_CR55","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1182\/blood.V96.7.2520","volume":"96","author":"B Nieswandt","year":"2000","unstructured":"Nieswandt, B., Bergmeier, W., Rackebrandt, K., Gessner, J. E. & Zirngibl, H. Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice. Blood 96, 2520\u20132527 (2000).","journal-title":"Blood"},{"key":"254_CR56","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1182\/blood-2013-09-521484","volume":"124","author":"Y Shida","year":"2014","unstructured":"Shida, Y. et al. Analysis of the role of von Willebrand factor, platelet glycoprotein VI-, and \u03b12\u03b21-mediated collagen binding in thrombus formation. Blood 124, 1799\u20131807 (2014).","journal-title":"Blood"},{"key":"254_CR57","doi-asserted-by":"publisher","first-page":"23998","DOI":"10.1074\/jbc.M003803200","volume":"275","author":"B Nieswandt","year":"2000","unstructured":"Nieswandt, B. et al. Expression and function of the mouse collagen receptor glycoprotein VI is strictly dependent on its association with the FcR\u03b3 chain. J. Biol. Chem. 275, 23998\u201324002 (2000).","journal-title":"J. Biol. Chem."},{"key":"254_CR58","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1182\/blood-2003-05-1391","volume":"102","author":"S Gruner","year":"2003","unstructured":"Gruner, S. et al. Multiple integrin\u2013ligand interactions synergize in shear-resistant platelet adhesion at sites of arterial injury in vivo. Blood 102, 4021\u20134027 (2003).","journal-title":"Blood"},{"key":"254_CR59","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.1093\/emboj\/20.9.2120","volume":"20","author":"B Nieswandt","year":"2001","unstructured":"Nieswandt, B. et al. Glycoprotein VI but not \u03b12\u03b21 integrin is essential for platelet interaction with collagen. EMBO J. 20, 2120\u20132130 (2001).","journal-title":"EMBO J."},{"key":"254_CR60","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1111\/jth.12013","volume":"10","author":"S Hofmann","year":"2012","unstructured":"Hofmann, S., V\u00f6gtle, T., Bender, M., Rose-John, S. & Nieswandt, B. The SLAM family member CD84 is regulated by ADAM10 and calpain in platelets. J. Thromb. Haemost. 10, 2581\u20132592 (2012).","journal-title":"J. Thromb. Haemost."},{"key":"254_CR61","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1182\/blood.V95.3.886.003k45_886_893","volume":"95","author":"W Bergmeier","year":"2000","unstructured":"Bergmeier, W., Rackebrandt, K., Schroder, W., Zirngibl, H. & Nieswandt, B. Structural and functional characterization of the mouse von Willebrand factor receptor GPIb\u2013IX with novel monoclonal antibodies. Blood 95, 886\u2013893 (2000).","journal-title":"Blood"},{"key":"254_CR62","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1182\/blood.V94.2.684.414k36_684_693","volume":"94","author":"B Nieswandt","year":"1999","unstructured":"Nieswandt, B. et al. Acute systemic reaction and lung alterations induced by an antiplatelet integrin GPIIb\/IIIa antibody in mice. Blood 94, 684\u2013693 (1999).","journal-title":"Blood"},{"key":"254_CR63","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1055\/s-0038-1642666","volume":"74","author":"HC Hemker","year":"1995","unstructured":"Hemker, H. C. & Beguin, S. Thrombin generation in plasma: its assessment via the endogenous thrombin potential. Thromb. Haemost. 74, 134\u2013138 (1995).","journal-title":"Thromb. Haemost."},{"key":"254_CR64","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000071636","volume":"33","author":"HC Hemker","year":"2003","unstructured":"Hemker, H. C. et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol. Haemost. Thromb. 33, 4\u201315 (2003).","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"254_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-68438-9","volume":"10","author":"SLN Brouns","year":"2020","unstructured":"Brouns, S. L. N. et al. Platelet-primed interactions of coagulation and anticoagulation pathways in flow-dependent thrombus formation. Sci. Rep. 10, 11910 (2020).","journal-title":"Sci. Rep."},{"key":"254_CR66","doi-asserted-by":"publisher","first-page":"e453","DOI":"10.7717\/peerj.453","volume":"2","author":"S van der Walt","year":"2014","unstructured":"van der Walt, S. et al. scikit-image: image processing in Python. PeerJ 2, e453 (2014).","journal-title":"PeerJ"},{"key":"254_CR67","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676\u2013682 (2012).","journal-title":"Nat. Methods"},{"key":"254_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-02360-6","volume":"11","author":"V G\u00f6b","year":"2021","unstructured":"G\u00f6b, V. et al. Infarct growth precedes cerebral thrombosis following experimental stroke in mice. Sci. Rep. 11, 22887 (2021).","journal-title":"Sci. Rep."},{"key":"254_CR69","doi-asserted-by":"publisher","first-page":"e02752-19","DOI":"10.1128\/mBio.02752-19","volume":"11","author":"J Amich","year":"2020","unstructured":"Amich, J. et al. Three-dimensional light sheet fluorescence microscopy of lungs to dissect local host immune-Aspergillus fumigatus interactions. mBio 11, e02752-19 (2020).","journal-title":"mBio"},{"key":"254_CR70","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1161\/CIRCULATIONAHA.107.691279","volume":"115","author":"C Kleinschnitz","year":"2007","unstructured":"Kleinschnitz, C. et al. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb\/IIIa blockade on infarct size, functional outcome, and intracranial bleeding. Circulation 115, 2323\u20132330 (2007).","journal-title":"Circulation"},{"key":"254_CR71","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/path.1700900124","volume":"90","author":"KC Carstairs","year":"1965","unstructured":"Carstairs, K. C. The identification of platelets and platelet antigens in histological sections. J. Pathol. Bacteriol. 90, 225\u2013231 (1965).","journal-title":"J. Pathol. Bacteriol."}],"container-title":["Nature Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44161-023-00254-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-023-00254-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-023-00254-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,16]],"date-time":"2023-04-16T19:02:26Z","timestamp":1681671746000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44161-023-00254-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,23]]},"references-count":71,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["254"],"URL":"https:\/\/doi.org\/10.1038\/s44161-023-00254-6","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742600419.793598284","asserted-by":"object"}]},"ISSN":["2731-0590"],"issn-type":[{"value":"2731-0590","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,23]]},"assertion":[{"value":"23 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.B., D.S. and B.N. hold a patent on recombinant GPV for treating thrombotic diseases reporting sGPV (lacking a functional transmembrane domain) for use in the treatment or prevention of thrombotic diseases. Data on rhGPV preventing thrombus formation in vivo and reducing infarct volume in a tMCAO model in this study are partly covered by the patent (patent applicant, Julius-Maximilians-Universit\u00e4t W\u00fcrzburg; inventors, B.N., D.S., S.B.; patent published, title, soluble glycoprotein V for treating thrombotic diseases; WO 2017\/109212; US patent no. US 11,028,144 B2).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}